TH-302 plus gemcitabine (G+T) versus gemcitabine (G) in patients with previously untreated advanced pancreatic cancer (PAC).
David P. Ryan
No relevant relationships to disclose
Shantan G. Reddy
No relevant relationships to disclose
Nathan Bahary
No relevant relationships to disclose
Hope Elizabeth Uronis
No relevant relationships to disclose
Darren Sigal
No relevant relationships to disclose
Allen Lee Cohn
No relevant relationships to disclose
William R. Schelman
No relevant relationships to disclose
Joe Stephenson
No relevant relationships to disclose
Clarence Eng
No relevant relationships to disclose
Mitesh J. Borad
No relevant relationships to disclose